Indeed, all cases of SLCT with FOXL2 variants were seen in postmenopausal women with uterine bleeding or estrogenic manifestations, which is not the right clinical setting for SLCT but is reminiscent of clinical symptoms of adult granulosa cell tumors [8]. Here, FOXL2 is linked to granulosa cell tumor.